D-dimer: Not just an indicator of venous thrombosis but a predictor of asymptomatic hematogenous metastasis in gastric cancer patients

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Diao, Dongmei ^a   Wang, Zhe ^a   Cheng, Yao ^a   Zhang, Hao ^a   Guo, Qi ^a   Song, Yongchun ^a   Zhu, Kun ^a   Li, Kang ^a   Liu, Di ^a   Dang, Chengxue ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; CHINA; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CLINICAL INDICATOR; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HEMATOGENOUS METASTASIS; HISTOPATHOLOGY; HUMAN; IMMUNOASSAY; LATEX ENHANCED IMMUNOTURBIDIMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIMARY TUMOR; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; SURVIVAL RATE; TUMOR RECURRENCE; VEIN THROMBOSIS; VERY ELDERLY; YOUNG ADULT; BLOOD; METABOLISM; MIDDLE AGED; NEOPLASM METASTASIS; PATHOLOGY; STOMACH TUMOR; SURVIVAL; VENOUS THROMBOSIS;

BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; VENOUS THROMBOSIS;

EID: 84903693642     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101125     Document Type: Article

References (31)

1. Gupta GP, Massague J (2006) Cancer metastasis: building a framework. Cell 127: 679-695. (Pubitemid 44781029)
2. Biggerstaff JP, Weidow B, Vidosh J, Dexheimer J, Patel S, et al. (2006) Soluble fibrin inhibits monocyte adherence and cytotoxicity against tumor cells: implications for cancer metastasis. Thromb J 4: 12.
3. Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, et al. (2005) Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105: 178-185. (Pubitemid 40053080)
4. Gay LJ, Felding-Habermann B (2011) Contribution of platelets to tumour metastasis. Nat Rev Cancer 11: 123-134.
5. Im JH, Fu W, Wang H, Bhatia SK, Hammer DA, et al. (2004) Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res 64: 8613-8619. (Pubitemid 39552074)
6. Ay C, Vormittag R, Dunkler D, Simanek R, Chiriac AL, et al. (2009) D-dimer and prothrombin fragment 1+2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol 27: 4124-4129.
7. Dompmartin A, Ballieux F, Thibon P, Lequerrec A, Hermans C, et al. (2009) Elevated D-dimer level in the differential diagnosis of venous malformations. Arch Dermatol 145: 1239-1244.
8. Righini M, Perrier A, De Moerloose P, Bounameaux H (2008) D-Dimer for venous thromboembolism diagnosis: 20 years later. J Thromb Haemost 6: 1059-1071. (Pubitemid 351859113)
9. Lippi G, Franchini M, Biasiutti C, Dellagiacoma G, Salvagno GL, et al. (2007) Increased D-dimer value and occult cancer in the absence of detectable thrombosis. Haematologica 92: e53-55.
10. Tomimaru Y, Yano M, Takachi K, Kishi K, Miyashiro I, et al. (2006) Plasma Ddimer levels show correlation with number of lymph node metastases in patients with esophageal cancer. J Am Coll Surg 202: 139-145. (Pubitemid 43000354)
11. Altiay G, Ciftci A, Demir M, Kocak Z, Sut N, et al. (2007) High plasma D-dimer level is associated with decreased survival in patients with lung cancer. Clin Oncol (R Coll Radiol) 19: 494-498. (Pubitemid 47181178)
12. Antoniou D, Pavlakou G, Stathopoulos GP, Karydis I, Chondrou E, et al. (2006) Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer. Lung Cancer 53: 205-210. (Pubitemid 43994226)
13. Batschauer AP, Figueiredo CP, Bueno EC, Ribeiro MA, Dusse LM, et al. (2010) D-dimer as a possible prognostic marker of operable hormone receptor-negative breast cancer. Ann Oncol 21: 1267-1272.
14. Kwon HC, Oh SY, Lee S, Kim SH, Han JY, et al. (2008) Plasma levels of prothrombin fragment F1+2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients. Jpn J Clin Oncol 38: 2-7. (Pubitemid 351248114)
15. Kilic M, Yoldas O, Keskek M, Ertan T, Tez M, et al. (2008) Prognostic value of plasma D-dimer levels in patients with colorectal cancer. Colorectal Dis 10: 238-241. (Pubitemid 351284674)
16. Mirshahi SS, Pujade-Lauraine E, Soria C, Mirshahi M, Fretault J, et al. (1992) D-dimer and CA 125 levels in patients with ovarian cancer during antineoplastic therapy. Prognostic significance for the success of anti-cancer treatment. Cancer 69: 2289-2292.
17. Ay C, Dunkler D, Pirker R, Thaler J, Quehenberger P, et al. (2012) High Ddimer levels are associated with poor prognosis in cancer patients. Haematologica 97: 1158-1164.
18. Raj SD, Zhou X, Bueso-Ramos CE, Ravi V, Patel S, et al. (2012) Prognostic significance of elevated D-dimer for survival in patients with sarcoma. Am J Clin Oncol 35: 462-467.
19. Stender MT, Larsen TB, Sorensen HT, Thorlacius-Ussing O (2012) Preoperative plasma D-dimer predicts 1-year survival in colorectal cancer patients with absence of venous thromboembolism (VTE): a prospective clinical cohort study. J Thromb Haemost 10: 2027-2031.
20. Tas F, Ciftci R, Kilic L, Bilgin E, Keskin S, et al. (2012) Clinical and prognostic significance of coagulation assays in melanoma. Melanoma Res 22: 368-375.
21. Yamamoto M, Yoshinaga K, Matsuyama A, Iwasa T, Osoegawa A, et al. (2012) Plasma D-dimer level as a mortality predictor in patients with advanced or recurrent colorectal cancer. Oncology 83: 10-15.
22. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
23. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150. (Pubitemid 46655601)
24. Ahn HS, Shin YS, Park PJ, Kang KN, Kim Y, et al. (2012) Serum biomarker panels for the diagnosis of gastric adenocarcinoma. Br J Cancer 106: 733-739.
25. Diao D, Zhu K, Wang Z, Cheng Y, Li K, et al. (2013) Prognostic value of the Ddimer test in oesophageal cancer during the perioperative period. J Surg Oncol 108: 34-41.
26. Horowitz NA, Blevins EA, Miller WM, Perry AR, Talmage KE, et al. (2011) Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain. Blood 118: 2889-2895.
27. Labelle M, Begum S, Hynes RO (2011) Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20: 576-590.
28. van den Berg YW, Osanto S, Reitsma PH, Versteeg HH (2012) The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood 119: 924-932.
29. Zhang W, Dang S, Hong T, Tang J, Fan J, et al. (2012) A humanized singlechain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor microenvironment. Blood 120: 2889-2898.
30. Palumbo JS, Kombrinck KW, Drew AF, Grimes TS, Kiser JH, et al. (2000) Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 96: 3302-3309.
31. Palumbo JS, Potter JM, Kaplan LS, Talmage K, Jackson DG, et al. (2002) Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res 62: 6966-6972. (Pubitemid 35424088)